Interim Results of a Prospective Prostate-Specific Membrane Antigen-Directed Focal Stereotactic Reirradiation Trial for Locally Recurrent Prostate Cancer.

Published on Jul 11, 2020in International Journal of Radiation Oncology Biology Physics5.859
· DOI :10.1016/J.IJROBP.2020.07.014
Sarah Bergamin4
Estimated H-index: 4
(USYD: University of Sydney),
Thomas Eade27
Estimated H-index: 27
(USYD: University of Sydney)
+ 9 AuthorsGeorge Hruby26
Estimated H-index: 26
(USYD: University of Sydney)
Sources
Abstract
Abstract Purpose To report the feasibility, toxicity, and preliminary outcomes (metabolic and biochemical) of 68Ga-PSMA PET/CT directed focal prostate re-irradiation using linear accelerator (LINAC) based stereotactic body radiation treatment (SBRT). Methods and Materials From March 2016 to March 2019 25 patients were enrolled in a prospective single institution trial (XXX). Eligibility criteria included patients with biopsy proven isolated prostate recurrence following definitive irradiation, with concordant multi-parametric MRI and 68Ga-PSMA PET/CT findings, and a PSA of less than 15ng/mL at the time of recurrence. The study included a sequential dose escalation component with the first 18 patients receiving 36Gy in 6 fractions on alternate days with subsequent patients receiving 38Gy in 6 fractions assuming acceptable toxicity. Results Median age was 72 years (range 62-83) with a median time between first RT and salvage SBRT of 8.3 years (range 4.5- 13.6 years). Median PSA at re-irradiation was 4.1 (range 1.1 to 16.6). The median follow-up was 25 months (range 13-46 months). Acute grade 1 and 2 genitourinary (GU) toxicity occurred in 6 (24%) and 1 (4%) men respectively. Acute grade 1 gastrointestinal (GI) toxicity occurred in 8% with one acute grade 3 GI toxicity (4%) due to a rectal ulcer overlying the hydrogel. Late grade 1 and 2 GU toxicity occurred in 28% and 4%. Late grade 1 GI toxicity occurred in 8% with no grade 2 or greater toxicity. Twenty-four patients have undergone per-protocol 12 month 68Ga-PSMA PET/CT, of which 23 (92%) demonstrated a complete metabolic response. Biochemical freedom from failure was 80% at 2 years with 3/4 of the biochemical failures exhibiting recurrent local disease. Conclusions PSMA-directed salvage focal re-irradiation to the prostate using LINAC-based SBRT is feasible and safe. Toxicity was low, with very favourable short term local and biochemical control in a carefully selected cohort of patients.
📖 Papers frequently viewed together
7 Citations
37 Citations
20204.72Biomedicines
12 Authors (Paola Caroli, ..., Antonino Romeo)
2 Citations
References29
Newest
Abstract Purpose /Objectives: We evaluated the use of HDR-like stereotactic body radiation therapy (SBRT) retreatment for biopsy proven local persistence in the prostate post-radiotherapy (RT), evaluating efficacy and toxicity. Methods and Materials From 2009–2018, 50 patients with biopsy-proven recurrent prostate cancer >2 years after prior treatment were retreated with an HDR-like dose of 3400 cGy over 5 fractions. Previous radiotherapy dose measured 75.6 Gy (64.8–81.0) and median salvage inte...
21 CitationsSource
#1Catarina Dinis Fernandes (NKI-AVL: Netherlands Cancer Institute)H-Index: 4
#2Petra J. van Houdt (NKI-AVL: Netherlands Cancer Institute)H-Index: 11
Last. Uulke A. van der Heide (NKI-AVL: Netherlands Cancer Institute)H-Index: 21
view all 11 authors...
BACKGROUND: Post-radiotherapy locally recurrent prostate cancer (PCa) patients are candidates for focal salvage treatment. Multiparametric MRI (mp-MRI) is attractive for tumor localization. However, radiotherapy-induced tissue changes complicate image interpretation. To develop focal salvage strategies, accurate tumor localization and distinction from benign tissue is necessary. PURPOSE: To quantitatively characterize radio-recurrent tumor and benign radiation-induced changes using mp-MRI, and i...
14 CitationsSource
#1Amalia Palacios-Eito (Sofia University)H-Index: 2
#2Amelia Béjar-Luque (Sofia University)H-Index: 1
Last. Sonia García-Cabezas (Sofia University)H-Index: 2
view all 4 authors...
: Technological advances in radiotherapy have led to the introduction of techniques such as stereotactic body radiation therapy (SBRT), allowing the administration of ablative doses. The hypothesis that oligometastatic disease may be cured through local eradication therapies has led to the increasing use of SBRT in patients with this type of disease. At the same time, scientific advances are being made to allow the confirmation of clinically suspected oligometastatic status at molecular level. T...
16 CitationsSource
#1M. Maenhout (UU: Utrecht University)H-Index: 9
#2Max Peters (UU: Utrecht University)H-Index: 13
Last. Jochem R.N. van der Voort van Zyp (UU: Utrecht University)H-Index: 14
view all 9 authors...
PURPOSE: To describe toxicity, biochemical outcome and quality of life after MRI guided focal high dose rate brachytherapy (HDR-BT) in a single fraction of 19 Gy for localized prostate cancer. MATERIALS AND METHODS: Between May 2013 and April 2016, 30 patients were treated by MRI-guided focal HDR-BT. Patients with visible tumour on MRI were included. All patients were ≥65 years, T-stage
13 CitationsSource
#1Jure Murgic (U of T: University of Toronto)H-Index: 8
#2Gerard Morton (Sunnybrook Health Sciences Centre)H-Index: 35
Last. Hans T. Chung (U of T: University of Toronto)H-Index: 17
view all 11 authors...
Purpose Although increasing data support whole-gland salvage therapy for recurrent prostate cancer, toxicity remains a significant concern. We hypothesized that focal therapy, treating only a portion of the prostate containing recurrent disease, might be equally effective and associated with less toxicity. The objectives of this prospective study were to explore the toxicities, quality of life, and efficacy of focal salvage high-dose-rate (HDR) brachytherapy in patients with multiparametric magn...
37 CitationsSource
#1Sangeeta Taneja (Apollo Hospitals)H-Index: 11
#2Amarnath Jena (Apollo Hospitals)H-Index: 12
Last. Aashim Ahuja (Apollo Hospitals)H-Index: 3
view all 5 authors...
OBJECTIVE. The purpose of this study is to assess whether temporal changes in 68Ga–prostate-specific membrane antigen (PSMA)–HBED-CC uptake and multiparametric MRI parameters derived using PET/MRI can aid in characterization of benign and malignant prostate lesions. MATERIALS AND METHODS. Thirty-five men with 29 malignant and six benign prostate lesions undergoing complete clinical workup including histologic analysis were enrolled for this retrospective study. All had undergone simultaneous who...
13 CitationsSource
#1Mauro Loi (UniFI: University of Florence)H-Index: 13
#2V. Di CataldoH-Index: 4
Last. Lorenzo Livi (UniFI: University of Florence)H-Index: 28
view all 14 authors...
Abstract Aims Robotic stereotactic body radiotherapy (rSBRT) to local recurrences emerged as a valuable option for exclusive local failure after prior external beam radiation therapy (EBRT) for localised prostate cancer. The aim of this study was to assess the efficacy and safety of rSBRT in patients experiencing locally recurrent prostate cancer after prior definitive or postoperative radiotherapy using the Cyberknife. Materials and methods Data from 50 patients were retrospectively reviewed. L...
24 CitationsSource
#1Marisa A. Kollmeier (MSK: Memorial Sloan Kettering Cancer Center)H-Index: 33
#2Sean McBride (MSK: Memorial Sloan Kettering Cancer Center)H-Index: 24
Last. Michael J. Zelefsky (MSK: Memorial Sloan Kettering Cancer Center)H-Index: 117
view all 11 authors...
Abstract Background Salvage brachytherapy is a treatment option for patients with locally recurrent prostate cancer after primary radiation therapy. We reviewed our experience using low-dose-rate (LDR) or high-dose-rate (HDR) brachytherapy to compare the outcome and toxicity profiles of each approach in the salvage brachytherapy setting. Methods and Materials Ninety-eight patients with biopsy-proven locally recurrent prostate cancer who underwent salvage brachytherapy (LDR = 37; HDR = 61) follow...
44 CitationsSource
#1Aurélie Mbeutcha (University of Nice Sophia Antipolis)H-Index: 9
#2Laurent ChauveincH-Index: 20
Last. Jean-Michel Hannoun-Levi (University of Nice Sophia Antipolis)H-Index: 23
view all 9 authors...
Background Optimal management of locally recurrent prostate cancer after definitive radiation therapy is still challenging. With the development of highly accurate radiotherapy devices, prostate salvage re-irradiation might generate lower toxicity rates than classical salvage therapies. We retrospectively evaluated the toxicity and the feasibility of a prostate re-irradiation after definitive radiation therapy failure. Two modalities were investigated: high-dose-rate brachytherapy (HDRB) on whol...
43 CitationsSource
#1George Hruby (USYD: University of Sydney)H-Index: 26
#2Thomas Eade (USYD: University of Sydney)H-Index: 27
Last. Carol Kwong (RNSH: Royal North Shore Hospital)H-Index: 3
view all 10 authors...
Abstract Background and purpose We investigated the role of 68 Ga-PSMA-PET (PSMA) to determine the location of disease recurrence in those with a rising PSA following definitive external beam radiation treatment (EBRT). Materials and methods 538men were treated with image guided EBRT to a dose of 78 or 82Gy between 2007 and 2014. Patients at least 24months post EBRT with biochemical failure (nadir+2) underwent PSMA scanning. Local recurrence (LR) was defined as increased uptake within the prosta...
27 CitationsSource
Cited By10
Newest
#1David BuchserH-Index: 4
Last. Felipe Couñago (UEM: European University of Madrid)H-Index: 8
view all 9 authors...
Although dose escalation protocols have improved biochemical control in prostate cancer radiotherapy, 10-45% of patients will experience disease recurrence. The prostate and seminal vesicles are the most frequent site of the first relapse. Traditionally, these patients have been managed with hormonal therapy, which is not curative. Recent improvements in diagnostic tests (e.g., multiparametric magnetic resonance and molecular imaging, including PET/CT scan with choline or Ga-PSMA) and new treatm...
Source
#1P. Graff (Curie Institute)
#2Gilles Crehange (Curie Institute)H-Index: 10
Resume null null Encore emergente il y a quelques annees, la radiotherapie stereotaxique s’est imposee comme une option valide de prise en charge du cancer localise de la prostate. Les proprietes intrinseques de l’adenocarcinome prostatique (faible rapport α/β) en font un excellent candidat. Nous proposons une revue des donnees de la litterature qui valident l’utilisation de cette technique emergente avec une mise en perspective des resultats, de leurs limites et des axes de developpement. La te...
Source
#1Yufeng Wang (USYD: University of Sydney)H-Index: 6
#2Sirisha Tadimalla (USYD: University of Sydney)H-Index: 4
Last. Annette Haworth (USYD: University of Sydney)H-Index: 23
view all 5 authors...
Magnetic resonance imaging (MRI) is increasingly used in the management of prostate cancer (PCa). Quantitative MRI (qMRI) parameters, derived from multi-parametric MRI, provide indirect measures of tumour characteristics such as cellularity, angiogenesis and hypoxia. Using Artificial Intelligence (AI), relevant information and patterns can be efficiently identified in these complex data to develop quantitative imaging biomarkers (QIBs) of tumour function and biology. Such QIBs have already demon...
Source
#1Matthew RichardsonH-Index: 4
Last. Jarad Martin (University of Newcastle)H-Index: 26
view all 9 authors...
INTRODUCTION The prostatic urethra is an organ at risk for prostate radiotherapy with genitourinary toxicities a common side effect. Many external beam radiation therapy protocols call for urethral sparing, and with modulated radiotherapy techniques, the radiation dose distribution can be controlled so that maximum doses do not fall within the prostatic urethral volume. Whilst traditional diagnostic MRI sequences provide excellent delineation of the prostate, uncertainty often remains as to the ...
1 CitationsSource
#2Giulia MarvasoH-Index: 14
Last. Piet OstH-Index: 41
view all 36 authors...
Abstract Background and purpose Between 30% and 47% of patients treated with definitive radiotherapy (RT) for prostate cancer are at risk of intraprostatic recurrence during follow-up. Re-irradiation with stereotactic body RT (SBRT) is emerging as a feasible and safe therapeutic option. However, no consensus or guidelines exist on this topic. The purpose of this ESTRO ACROP project is to investigate expert opinion on salvage SBRT for intraprostatic relapse after RT. Materials and Methods A 40-it...
3 CitationsSource
SpaceOAR, an absorbable polyethylene glycol hydrogel, increases the space between the prostate and rectum to reduce the radiation received by the rectum during prostate cancer radiation therapy. The objective of this systematic review was to evaluate controlled studies on the dosimetric and clinical outcomes of SpaceOAR in men undergoing external beam radiation therapy for localized prostate cancer. Eight studies were included in the review. All of the studies showed SpaceOAR to reduce the radia...
Source
#1Sympascho Young (London Health Sciences Centre)
#2Wei Liu (London Health Sciences Centre)H-Index: 3
Last. Glenn Bauman (London Health Sciences Centre)H-Index: 53
view all 4 authors...
PSMA targeted PET/CT is a “Next Generation Imaging” technique with superior sensitivity and specificity for detecting recurrent prostate cancer compared with conventional imaging, allowing more acc...
2 CitationsSource
#1Elisha T. Fredman (University Hospitals of Cleveland)H-Index: 5
#2Bryan Traughber (University Hospitals of Cleveland)H-Index: 13
Last. Mitchell Machtay (University Hospitals of Cleveland)H-Index: 31
view all 11 authors...
Introduction: Advances in multiparametric MRI (mpMRI) combining anatomic and functional imaging can accurately identify foci of adenocarcinoma within the prostate, offering the possibility of partial gland therapy. We performed tandem prospective pilot trials to investigate the feasibility of focal prostate SBRT (f-SBRT) based on correlating diagnostic mpMRI and biopsies with confirmatory pathology in treatment planning. Materials and Methods: Patients with pathologic focal Gleason 6-7 disease a...
Source
#1Alexandre Taillez (university of lille)
Last. David Pasquier (university of lille)H-Index: 22
view all 6 authors...
Background Understanding intra-fractional prostate motions is crucial for stereotactic body radiation therapy (SBRT). No studies have focused on the intra-fractional prostate motions during re-irradiation with SBRT. The objective was to evaluate these translational and rotational motions in primary treated patients and in the context of re-irradiation. Methods From January 2011 to March 2020, 162 patients with histologically proven prostate cancer underwent prostate SBRT, including 58 as part of...
Source
#1Jim Zhong (University of Leeds)
#2F. Slevin (University of Leeds)H-Index: 3
Last. Ann HenryH-Index: 32
view all 8 authors...
Source